EvaluateBLEX 404
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EvaluateBLEX 404, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer [Phase 2]